Table 3.
History of treatment and knowledge of AMD.
| Cohort 1-1 (Discontinued Due to the Doctor’s Decision) |
Cohort 1-2 (Discontinued Due to Their Own Decision) |
Cohort 2 (Continuing Treatment) |
|
|---|---|---|---|
| n | 185 | 22 | 65 |
| Type of hospital | |||
| Eye clinic | 42 (22.7) | 10 (45.5) | 13 (20.0) |
| Eye hospital with referral | 123 (66.5) | 8 (36.4) | 47 (72.3) |
| Eye hospital without referral | 20 (10.8) | 4 (18.2) | 5 (7.7) |
| Time to hospital | |||
| <30 min | 77 (41.6) | 7 (31.8) | 31 (47.7) |
| 30–59 min | 76 (41.1) | 10 (45.5) | 19 (29.2) |
| 1 to <1.5 h | 21 (11.4) | 2 (9.1) | 11 (16.9) |
| ≥1.5 h | 11 (5.9) | 3 (13.6) | 4 (6.2) |
| Method of transport to hospital | |||
| Car | 71 (38.4) | 11 (50.0) | 21 (32.3) |
| Taxi | 2 (1.1) | 1 (4.5) | 1 (1.5) |
| Public transport | 85 (45.9) | 7 (31.8) | 34 (52.3) |
| Bicycle | 13 (7.0) | 1 (4.5) | 2 (3.1) |
| Foot | 14 (7.6) | 2 (9.1) | 7 (10.8) |
| Accompanied by someone | |||
| Yes | 41 (22.2) | 8 (36.4) | 14 (21.5) |
| No | 144 (77.8) | 14 (63.6) | 51 (78.5) |
| Treatment duration | |||
| <3 months | 55 (29.7) | 7 (31.8) | 4 (6.2) |
| ≥3 months | 52 (28.1) | 7 (31.8) | 7 (10.8) |
| ≥1 year | 37 (20.0) | 5 (22.7) | 23 (35.4) |
| ≥3 years | 24 (13.0) | 3 (13.6) | 16 (24.6) |
| ≥5 years | 17 (9.2) | 0 | 15 (23.1) |
| Visit frequency | |||
| Monthly | 102 (55.1) | 11 (50.0) | 29 (44.6) |
| Every 2 months | 37 (20.0) | 5 (22.7) | 24 (36.9) |
| Every 3 months | 28 (15.1) | 1 (4.5) | 11 (16.9) |
| Every 6 months | 7 (3.8) | 2 (9.1) | 0 |
| None of the above | 11 (5.9) | 3 (13.6) | 1 (1.5) |
| Injection frequency | |||
| Monthly | 57 (30.8) | 4 (18.2) | 10 (15.4) |
| Every 2 months | 38 (20.5) | 6 (27.3) | 19 (29.2) |
| Every 3 months | 27 (14.6) | 1 (4.5) | 25 (38.5) |
| Every 6 months | 11 (5.9) | 3 (13.6) | 7 (10.8) |
| None of the above | 52 (28.1) | 8 (36.4) | 4 (6.2) |
| Out-of-pocket payment (JPY) | |||
| <10,000 | 38 (20.5) | 5 (22.7) | 9 (13.8) |
| 10,000–29,999 | 40 (21.6) | 7 (31.8) | 26 (40.0) |
| 30,000–49,999 | 50 (27.0) | 5 (22.7) | 22 (33.8) |
| ≥50,000 | 57 (30.8) | 5 (22.7) | 8 (12.3) |
| Relationship with their doctor | |||
| Very good | 45 (24.3) | 1 (4.5) | 17 (26.2) |
| Good | 68 (36.8) | 7 (31.8) | 23 (35.4) |
| Neither good nor bad | 67 (36.2) | 13 (59.1) | 22 (33.8) |
| Not good | 2 (1.1) | 1 (4.5) | 3 (4.6) |
| Not good at all | 3 (1.6) | 0 | 0 |
| Understanding of AMD at the start of treatment | |||
| Good | 34 (18.4) | 5 (22.7) | 16 (24.6) |
| Quite good | 78 (42.2) | 8 (36.4) | 22 (33.8) |
| Not quite good | 49 (26.5) | 6 (27.3) | 17 (26.2) |
| Not good at all | 24 (13.0) | 3 (13.6) | 10 (15.4) |
| Current understanding of AMD | |||
| Good | 58 (31.4) | 4 (18.2) | 29 (44.6) |
| Quite good | 116 (62.7) | 13 (59.1) | 35 (53.8) |
| Not quite good | 10 (5.4) | 4 (18.2) | 1 (1.5) |
| Not good at all | 1 (0.5) | 1 (4.5) | 0 |
Values are n (%); AMD, age-related macular degeneration.